Pure Global AI
Disease / condition

Influenza clinical trials

Free access to 1,074 studies10+ countriesUpdated daily50 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,074
Total trials
10+
Countries
10+
Sponsors
50
Recruiting
By phase
N/A228
Phase 3224
Phase 2185
Phase 4184
Phase 1146
By status
Completed837
Unknown73
Recruiting50
Not yet recruit...45
Terminated29
Top countries
United States of America341
China73
United Kingdom49
Japan46
Canada38
Top sponsors
GlaxoSmithKline139
National Institute...108
Sanofi Pasteur, a ...58
MedImmune LLC27
Novartis Vaccines27
Recent trials
Latest clinical trials for Influenza
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
Shanghai Institute Of Biologic...
NCT06342349Not yet recr...
Phase
Phase 1
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities
Denver Health and Hospital Aut... · United States of America
NCT06274359Not yet recr...
Evaluation of a Screen and Treat Protocol for Influenza
Tricore, Inc
NCT06207058Not yet recr...
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
Vaxess Technologies · Canada
NCT06125717Completed
Phase
Phase 1
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Federico Martinón Torres · Spain
NCT06141655Recruiting
Phase
Phase 4
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
The Archer-Daniels-Midland Com... · Greece
NCT06103994Recruiting
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza
Hoffmann-La Roche · United States of America
NCT06094010Recruiting
Phase
Phase 3
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Centers for Disease Control an... · Peru
NCT06054269Recruitment ...
Phase
Phase 3
Safety and Efficacy of DSM 32444 in the Treatment of Acute Upper Respiratory Infection
Huro Biotech Joint Stock Compa... · Vietnam
NCT05999955Completed
Influenza viral shedding after treatment with and anti-influenza drug
Japan Physicians Association I... · Japan
UMIN000051775Completed
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
National Institute of Allergy ... · United States of America
NCT05968989Recruiting
Phase
Phase 1
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
ModernaTX, Inc. · United States of America
NCT05972174Recruiting
Phase
Phase 1/2
Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases
AstraZeneca · United Kingdom
NCT06077045Completed
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
National Institute of Allergy ... · United States of America
NCT05945485Not yet recr...
Phase
Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
ModernaTX, Inc. · United States of America
NCT05868382Not yet recr...
Phase
Phase 2
Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais
Mahidol University · Thailand
NCT05895955Not yet recr...
Phase
Phase 1/2
Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months
Sanofi · South Korea
NCT05832333Completed
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
University of Colorado, Denver
NCT05832307Not yet recr...
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults
National Institute of Allergy ... · United States of America
NCT05755620Not yet recr...
Phase
Phase 1
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.
Osivax · Australia
NCT05734040Recruiting
Phase
Phase 2
View all 1,074 trials →
About this profile

Access comprehensive clinical trial information for Influenza through Pure Global AI's free database. This collection includes 1,074 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 50 trials are actively recruiting participants.

Research for Influenza is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include GlaxoSmithKline and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,074 clinical trials studying Influenza, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi Pasteur, a Sanofi Company, among others.